“Big Design-software Companies In Talks To Merge; An Acquisition By Synopsys Of Ansys, Which Has A Market Value Of Nearly $30B, Could Be Struck Early In 2024” – WSJ

Synopsys is in talks to acquire Ansys in a move that would create a new design-software giant and mark one of the first big merger deals of the new year. An acquisition of Ansys, which has a market value of nearly $30 billion, could be struck early in 2024, according to people familiar with the matter. The talks could still fall apart, and another suitor could emerge.

“Big Design-software Companies In Talks To Merge; An Acquisition By Synopsys Of Ansys, Which Has A Market Value Of Nearly $30B, Could Be Struck Early In 2024” – WSJ Read Post »

Cisco Systems Is Paying Around $650M In Cash For The Startup Isovalent

Cisco Systems’ acquisition of Isovalent, a cloud networking and security startup backed by Google and Microsoft, announced on Thursday, suggests that the enterprise software stock rebound is also boosting startup valuations in the sector. Cisco, a pioneer in data center networking equipment that has shifted to serve cloud customers, is paying around $650 million in cash for the startup, or 32 times its annual recurring revenue, said a person with direct knowledge of the figure. That’s well above the average valuation multiple for enterprise software stocks outside artificial intelligence, which are trading at 8.2 times ARR, according to Meritech

Cisco Systems Is Paying Around $650M In Cash For The Startup Isovalent Read Post »

CFRA analyst Zachary Warring underlined that Nike’s competitors could eat into some of the demand

CFRA analyst Zachary Warring underlined that Nike’s competitors could eat into some of the demand. “Although Nike maintains a fortress balance sheet with significant capital returns, we believe the multiple will trend back down to pre-pandemic levels as the company faces competition from brands like Hoka and On [Holding] while it looks for new growth drivers and focuses on cutting costs,” Warring said.

CFRA analyst Zachary Warring underlined that Nike’s competitors could eat into some of the demand Read Post »

Nike’s Growth Hinges On ‘Newness,’ But One Analyst Says Its Fastest-Growing Segment Is At Risk

After posting softer-than-expected revenue guidance in its fiscal second-quarter earnings, Nike Inc. (NYSE:NKE) is banking on “newness and innovation” to drive growth. However, one analyst struck a discordant note, stating that its fastest-growing piece of business is at risk. What Happened: ‘Just Do It’ might not be working for Nike, but analysts were largely positive on the company’s prospects, with most ratings being “Buy,” “Outperform,” or “Overweight.” However, TD Cowen analyst John Kernan is not as optimistic about Nike’s strategy, casting doubt on the growth prospects of the sneaker maker. “Nike needs improved marketing outside of basketball, streetwear and lifestyle trends,” Kernan said in a research note on Friday, downgrading the stock from “Outperform” to “Market Perform.” “Nike faces disruption from smaller competitors in footwear and apparel. Jordan brand moving into lower price points and away from a scarcity model creates risk to the fastest-growing piece of the business,” Kernan

Nike’s Growth Hinges On ‘Newness,’ But One Analyst Says Its Fastest-Growing Segment Is At Risk Read Post »

Oracle (NYSE:ORCL) stock Analyst Ratings

Oracle (NYSE:ORCL) stock Analyst Ratings Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 12/22/2023 — Erste Group Downgrades Buy → Hold 12/12/2023 0.41% Morgan Stanley $107 → $106 Maintains Equal-Weight 12/12/2023 23.14% Evercore ISI Group $135 → $130 Maintains Outperform 12/12/2023 23.14% Wolfe Research $140 → $130 Maintains Outperform 12/12/2023 19.35% BMO Capital $130 → $126 Maintains Market Perform 12/12/2023 18.4% UBS $135 → $125 Maintains Buy 12/12/2023 18.4% Piper Sandler $130 → $125 Maintains Overweight 11/13/2023 — Edward Jones Upgrades Hold → Buy 10/23/2023 1.35% Morgan Stanley $106 → $107 Maintains Equal-Weight 10/09/2023 27.88% Evercore ISI Group $131 → $135 Upgrades In-Line → Outperform 09/25/2023 23.14% BMO Capital $132 → $130 Maintains Market Perform 09/22/2023 42.09% Guggenheim → $150 Reiterates Buy → Buy 09/22/2023 23.14% Piper Sandler → $130 Reiterates Overweight → Overweight 09/21/2023 4.2% Berenberg $82.5 → $110 Maintains Hold 09/19/2023 42.09% Mizuho

Oracle (NYSE:ORCL) stock Analyst Ratings Read Post »

CFRA Reiterates Buy Opinion On Shares Of Jpmorgan Chase & Co.

CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We think a wider risk premium for JPM shares can be supported by our view of a soft landing for the U.S. economy and lower rates that propel higher borrowing and risk taking. We raise our target by $15 to $190 on a forward P/E of 11.9x our 2024 earnings estimate, still below the three-year historic average of 12.3x. We keep our EPS estimates at $17.00 for 2023 and at $15.95 for 2024; our revenue forecast is $160B for 2023 and $159.5B for 2024. Loan growth remains critical, in our view, to net interest income (NII) and noninterest income in 2024, assuming economic growth and no recession. In Q3 2023, NII rose 30% Y/Y, with a rise in interest rate spread to 2.00% vs. 1.79% Y/Y (1.97%

CFRA Reiterates Buy Opinion On Shares Of Jpmorgan Chase & Co. Read Post »

Exxon Mobil (NYSE:XOM) stock Analyst Ratings

Exxon Mobil (NYSE:XOM) stock Analyst Ratings Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 12/22/2023 — Erste Group Downgrades Buy → Hold 12/14/2023 30% UBS $138 → $133 Maintains Buy 12/08/2023 24.13% JP Morgan $134 → $127 Maintains Overweight 12/07/2023 17.29% RBC Capital → $120 Reiterates Sector Perform → Sector Perform 11/14/2023 30% Mizuho $139 → $133 Maintains Buy 11/02/2023 38.79% UBS $143 → $142 Maintains Buy 10/25/2023 30.97% JP Morgan $137 → $134 Maintains Overweight 10/17/2023 36.84% Bernstein → $140 Initiates Coverage On → Outperform 10/12/2023 41.73% Jefferies $140 → $145 Maintains Buy 10/12/2023 17.29% RBC Capital → $120 Reiterates Sector Perform → Sector Perform 10/12/2023 28.04% Truist Securities $110 → $131 Upgrades Hold → Buy 10/04/2023 39.77% UBS $139 → $143 Maintains Buy 10/02/2023 30.97% Morgan Stanley $131 → $134 Maintains Overweight 09/25/2023 35.86% Mizuho → $139 Reiterates Buy → Buy 09/25/2023 28.04%

Exxon Mobil (NYSE:XOM) stock Analyst Ratings Read Post »

Intuitive Surgical (NASDAQ:ISRG) stock Analyst Ratings

Intuitive Surgical (NASDAQ:ISRG) stock Analyst Ratings Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 12/22/2023 16.71% Truist Securities $375 → $390 Maintains Buy 12/12/2023 12.23% Truist Securities $320 → $375 Maintains Buy 12/04/2023 -1.24% Morgan Stanley $300 → $330 Maintains Equal-Weight 11/17/2023 4.74% Stifel $315 → $350 Maintains Buy 11/17/2023 -4.83% HSBC → $318 Initiates Coverage On → Buy 10/23/2023 -10.22% Morgan Stanley $330 → $300 Maintains Equal-Weight 10/20/2023 -2.74% Piper Sandler $385 → $325 Maintains Overweight 10/20/2023 6.24% RBC Capital → $355 Reiterates Outperform → Outperform 10/20/2023 16.71% Citigroup $400 → $390 Maintains Buy 10/20/2023 8.63% Wells Fargo $386 → $363 Maintains Overweight 10/20/2023 -7.23% Raymond James $368 → $310 Maintains Outperform 10/16/2023 2.35% Leerink Partners → $342 Initiates Coverage On → Outperform 08/17/2023 7.74% RBC Capital → $360 Reiterates Outperform → Outperform 07/24/2023 -1.24% Morgan Stanley $310 → $330 Maintains Equal-Weight 07/24/2023 15.22%

Intuitive Surgical (NASDAQ:ISRG) stock Analyst Ratings Read Post »

CFRA Reiterates Buy Rating On Shares Of Morgan Stanley

CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: As a leading global investment bank, we think MS is poised to benefit from a potential rebound in M&A and debt/equity underwriting in the year ahead. We raise our 12-month target $15 to $105 on a forward P/E of 14.8x our 2024 earnings estimate, above the three-year historic average at 13.0x given our view of a cyclical rebound in MS’s businesses. We keep our earnings estimates for 2023 at $5.90 and 2024 at $7.10, both above consensus at $5.61 and $6.59. Even during a risk-off market, we think MS gained wallet share in the past year, with several European banks having retrenched from investment banking. The Fed’s signal of potential rate cuts in 2024 is likely to get corporates positioned for higher capital raising, debt refinancing, and

CFRA Reiterates Buy Rating On Shares Of Morgan Stanley Read Post »

Ross Stores (NASDAQ:ROST) Stock Analyst Ratings

Ross Stores (NASDAQ:ROST) Stock Analyst Ratings Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 12/22/2023 10.39% Wells Fargo $140 → $150 Maintains Overweight 11/17/2023 1.56% BMO Capital $127 → $138 Maintains Outperform 11/17/2023 3.03% Wells Fargo $135 → $140 Maintains Overweight 11/17/2023 0.82% Morgan Stanley $131 → $137 Maintains Overweight 11/17/2023 -0.65% Telsey Advisory Group $130 → $135 Maintains Market Perform 11/13/2023 -4.33% Telsey Advisory Group → $130 Reiterates Market Perform → Market Perform 11/07/2023 3.03% Evercore ISI Group → $140 Initiates Coverage On → Outperform 11/03/2023 -0.65% Gordon Haskett → $135 Upgrades Accumulate → Buy 08/18/2023 -0.65% Guggenheim $125 → $135 Maintains Buy 08/18/2023 -0.65% Loop Capital $125 → $135 Maintains Buy 08/18/2023 -2.86% TD Cowen $128 → $132 Maintains Outperform 08/18/2023 -3.59% Morgan Stanley $130 → $131 Maintains Overweight 08/18/2023 -38.18% UBS $80 → $84 Maintains Sell 08/18/2023 -6.54% BMO Capital $113 →

Ross Stores (NASDAQ:ROST) Stock Analyst Ratings Read Post »

Fiserv, Inc. (NYSE: FI) Stock Analyst Ratings

Fiserv, Inc. (NYSE: FI) Stock Analyst Ratings Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 12/22/2023 31.37% Tigress Financial $160 → $175 Maintains Buy 12/05/2023 14.11% BMO Capital → $152 Initiates Coverage On → Outperform 11/16/2023 12.6% UBS $140 → $150 Maintains Buy 11/16/2023 12.6% Mizuho $140 → $150 Maintains Buy 11/16/2023 8.1% RBC Capital → $144 Reiterates Outperform → Outperform 11/16/2023 12.6% Wedbush → $150 Reiterates Outperform → Outperform 11/16/2023 -0.16% Morgan Stanley $129 → $133 Maintains Equal-Weight 10/25/2023 31.37% Susquehanna $170 → $175 Maintains Positive 10/25/2023 10.35% Raymond James $145 → $147 Maintains Outperform 10/20/2023 5.1% UBS → $140 Assumes Buy → Buy 10/17/2023 -9.92% Truist Securities $130 → $120 Maintains Hold 08/22/2023 9.6% JP Morgan $136 → $146 Maintains Overweight 08/01/2023 8.1% RBC Capital → $144 Reiterates Outperform → Outperform 07/27/2023 -3.16% Morgan Stanley $126 → $129 Maintains Equal-Weight 07/27/2023 1.34% Stephens

Fiserv, Inc. (NYSE: FI) Stock Analyst Ratings Read Post »

Scroll to Top